End-of-day quote
Thailand S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
9.15
THB
|
+1.67%
|
|
+1.67%
|
-5.67%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,851
|
1,609
|
1,495
|
1,723
|
1,481
|
1,381
|
Enterprise Value (EV)
1 |
1,731
|
1,437
|
1,208
|
1,454
|
1,325
|
1,212
|
P/E ratio
|
11.7
x
|
18.5
x
|
18.4
x
|
14.6
x
|
32.5
x
|
19.4
x
|
Yield
|
7.69%
|
5.31%
|
5.43%
|
6.78%
|
3.94%
|
5.15%
|
Capitalization / Revenue
|
2.27
x
|
2.83
x
|
2.71
x
|
2.67
x
|
3.31
x
|
2.33
x
|
EV / Revenue
|
2.12
x
|
2.53
x
|
2.19
x
|
2.25
x
|
2.96
x
|
2.04
x
|
EV / EBITDA
|
8.37
x
|
13.2
x
|
11.1
x
|
9.53
x
|
19.4
x
|
12.8
x
|
EV / FCF
|
-92.5
x
|
9.29
x
|
6.71
x
|
53
x
|
-340
x
|
24.4
x
|
FCF Yield
|
-1.08%
|
10.8%
|
14.9%
|
1.89%
|
-0.29%
|
4.1%
|
Price to Book
|
3.15
x
|
3.05
x
|
2.86
x
|
3.01
x
|
2.99
x
|
2.79
x
|
Nbr of stocks (in thousands)
|
142,372
|
142,372
|
142,372
|
142,372
|
142,372
|
142,372
|
Reference price
2 |
13.00
|
11.30
|
10.50
|
12.10
|
10.40
|
9.700
|
Announcement Date
|
2/26/19
|
2/27/20
|
2/25/21
|
2/25/22
|
2/27/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
816.7
|
568.2
|
552
|
645.8
|
447
|
593.2
|
EBITDA
1 |
206.9
|
109.1
|
108.8
|
152.5
|
68.16
|
95.05
|
EBIT
1 |
192.1
|
96.27
|
97.3
|
143.9
|
59.61
|
85.17
|
Operating Margin
|
23.53%
|
16.94%
|
17.63%
|
22.27%
|
13.34%
|
14.36%
|
Earnings before Tax (EBT)
1 |
196.5
|
107.4
|
102.1
|
146.8
|
55.31
|
87.79
|
Net income
1 |
158
|
86.73
|
81.79
|
118.7
|
44.92
|
70.84
|
Net margin
|
19.35%
|
15.26%
|
14.82%
|
18.38%
|
10.05%
|
11.94%
|
EPS
2 |
1.110
|
0.6100
|
0.5700
|
0.8300
|
0.3200
|
0.5000
|
Free Cash Flow
1 |
-18.71
|
154.8
|
180.1
|
27.43
|
-3.891
|
49.67
|
FCF margin
|
-2.29%
|
27.24%
|
32.64%
|
4.25%
|
-0.87%
|
8.37%
|
FCF Conversion (EBITDA)
|
-
|
141.88%
|
165.5%
|
17.99%
|
-
|
52.26%
|
FCF Conversion (Net income)
|
-
|
178.46%
|
220.25%
|
23.11%
|
-
|
70.12%
|
Dividend per Share
2 |
1.000
|
0.6000
|
0.5700
|
0.8200
|
0.4100
|
0.5000
|
Announcement Date
|
2/26/19
|
2/27/20
|
2/25/21
|
2/25/22
|
2/27/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
120
|
172
|
287
|
269
|
156
|
169
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-18.7
|
155
|
180
|
27.4
|
-3.89
|
49.7
|
ROE (net income / shareholders' equity)
|
26.3%
|
15.6%
|
15.6%
|
21.7%
|
8.41%
|
14.3%
|
ROA (Net income/ Total Assets)
|
15.9%
|
8.39%
|
9.72%
|
13.9%
|
5.89%
|
9.27%
|
Assets
1 |
995.2
|
1,033
|
841.4
|
854.5
|
762.8
|
763.9
|
Book Value Per Share
2 |
4.120
|
3.700
|
3.670
|
4.020
|
3.480
|
3.470
|
Cash Flow per Share
2 |
0.1500
|
0.3700
|
0.6700
|
0.4900
|
0.3000
|
0.1700
|
Capex
1 |
5.69
|
7.83
|
1.1
|
1.27
|
14.3
|
17.4
|
Capex / Sales
|
0.7%
|
1.38%
|
0.2%
|
0.2%
|
3.21%
|
2.93%
|
Announcement Date
|
2/26/19
|
2/27/20
|
2/25/21
|
2/25/22
|
2/27/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -5.67% | 34.6M | | +2.36% | 3.58B | | -17.31% | 2.21B | | -9.80% | 1.85B | | +3.66% | 1.8B | | -1.86% | 1.6B | | +2.91% | 1.1B | | -22.39% | 1.02B | | -4.02% | 951M | | +2.36% | 846M |
Pesticide
|